Middle East And Africa Traumatic Brain Injury Treatment Market
Taille du marché en milliards USD
TCAC :
% 
USD
202.80 Million
USD
144.04 Million
2024
2032
 Période de prévision |
2025 –2032 |
 Taille du marché (année de référence) |
USD 202.80 Million |
 Taille du marché (année de prévision) |
USD 144.04 Million |
 TCAC |
% |
| Principaux acteurs du marché |
Segmentation du marché du traitement des traumatismes crâniens au Moyen-Orient et en Afrique, par traitement (chirurgie, soins d'urgence immédiats et médicaments), voie d'administration (parentérale, orale et autres), âge du patient (enfants, adolescents et personnes âgées), sexe (homme et femme), cause de blessure (chutes, circulation automobile, sports et autres), utilisateur final (hôpitaux, cliniques de neurologie, pharmacies indépendantes et autres) - Tendances et prévisions du secteur jusqu'en 2032
Taille du marché du traitement des lésions cérébrales traumatiques
- Le marché du traitement des lésions cérébrales traumatiques au Moyen-Orient et en Afrique était évalué à 202,80 millions USD en 2024 et devrait atteindre 144,04 millions USD d'ici 2032.
- Au cours de la période de prévision de 2025 à 2032, le marché devrait croître à un TCAC de 4,4 %, principalement en raison de l'incidence croissante des traumatismes crâniens (TCC).
- Cette croissance est due à des facteurs tels que l’incidence croissante des lésions cérébrales traumatiques (LCT), l’adoption croissante de procédures mini-invasives dans le traitement des LCT et la demande croissante de traitement des lésions cérébrales traumatiques.
Analyse du marché du traitement des traumatismes crâniens
- Le marché du traitement des lésions cérébrales traumatiques (LCT) devrait connaître une croissance significative en raison de la sensibilisation croissante aux LCT, des progrès des technologies de diagnostic et de l'incidence croissante des accidents et des blessures liées au sport, ce qui stimule la demande d'options de traitement efficaces et de thérapies de réadaptation.
- Le marché connaît une augmentation des traitements innovants, notamment des agents neuroprotecteurs, des thérapies à base de cellules souches et des technologies de réadaptation avancées, qui améliorent les résultats de la récupération et élargissent le paysage thérapeutique pour les patients atteints de lésions cérébrales traumatiques.
- L' Amérique du Nord se distingue comme l'une des régions dominantes pour le marché du traitement des lésions cérébrales traumatiques, grâce à une infrastructure de soins de santé avancée, des investissements importants dans la recherche et une forte prévalence de lésions cérébrales traumatiques.
Portée du rapport et segmentation du marché du traitement des lésions cérébrales traumatiques
|
Attributs |
Aperçu du marché du traitement des traumatismes crâniens |
|
Segments couverts |
|
|
Pays couverts |
Moyen-Orient et Afrique
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
Traumatic Brain Injury Treatment Market Trends
“Growing Adoption of Telemedicine in TBI Treatment”
- Telemedicine allows patients to receive remote consultations and rehabilitation services, improving access to specialized care for individuals in rural or underserved areas, thus facilitating timely intervention for TBI patients
- Utilizing telehealth reduces the costs associated with in-person visits, including travel expenses and lost productivity, making it a financially viable option for both patients and healthcare providers
- In March 2021, NCBI stated that Telehealth visits for patients with acquired brain injuries and their caregivers can ease the burden of transportation, improve compliance, and increase overall satisfaction. Management strategies are largely unaffected in the telehealth setting, and telerehab options have been found to be equal or superior to in-person therapy to treat many associated deficits
- Telemedicine platforms enable continuous monitoring and follow-up care, allowing healthcare professionals to track patient progress remotely, provide real-time feedback, and adjust treatment plans as necessary, ultimately enhancing patient outcomes in TBI management
Traumatic Brain Injury Treatment Market Dynamics
Driver
“Increasing Incidence of Traumatic Brain Injury (TBI)”
- As the number of cases continues to rise due to various contributing factors such as road accidents, sports-related injuries, and falls, particularly among the elderly population. Road traffic accidents remain one of the leading causes of TBI worldwide, with the growing number of vehicles on the road, reckless driving behaviours
- Sports-related injuries, particularly in contact sports like football, boxing, and rugby, have further fueled the surge in TBI cases, with increasing awareness of concussion-related complications prompting the need for advanced treatment solutions
For instance,
- In March 2025, as per the article published by ScienceDirect, there were 20.84 million incident cases and 37.93 million prevalent cases of Traumatic Brain Injury (TBI) Middle East and Africaly, leading to 5.48 million, Years Lived With Disability (YLDs). The rising burden of TBI increases the demand for advanced treatments, driving investments in diagnostics, neurosurgery, and rehabilitation, ultimately fueling the growth of the Middle East and Africa TBI treatment market
- In October 2024, according to the data published by Centers for Disease Control and Prevention, In 2021, there were 69,473 TBI-related deaths, and in 2020, approximately 214,110 hospitalizations occurred. This equates to over 586 hospitalizations and 190 deaths per day, with individuals aged 75+ and males being the most affected. The rising burden of TBI necessitates advanced treatment solutions, driving growth in the Middle East and Africa TBI treatment market
- Factors such as road accidents, sports injuries, and falls—especially among the elderly—contribute to increase in TBI. Growing awareness and demand for advanced treatments, including neurosurgery, drug therapies, and rehabilitation, are fuelling market expansion and technological advancements in TBI management
Opportunity
“Rising Personalized and Targeted Therapies in Traumatic Brain Injury (TBI)”
- TBI is a highly variable condition influenced by severity, location, and patient-specific factors, making traditional treatments less effective. Advances in biomarker discovery, neuroimaging, and computational modeling help identify distinct injury patterns, enabling more targeted therapies. Pharmacogenomics enhances drug selection and dosing, minimizing side effects while maximizing effectiveness. Personalized rehabilitation strategies, tailored to cognitive and motor impairments, further optimize recovery by aligning treatments with individual healing trajectories
For instance,
- In February 2022, as per NCBI, researchers have discovered genetic risk factors like APOE4 and BDNF Val66Met polymorphisms that impact TBI recovery. By focusing on these variations, personalized treatments can lower harmful biomarkers, enhance neuroprotection, and improve rehabilitation. This approach tailors’ therapies to individual needs, ultimately leading to better long-term functional outcomes for TBI patients
- In February 2024, article by MDPI TBI presents a significant opportunity to enhance patient outcomes. Advancements in biomarker discovery, pharmacogenomics, and neuroimaging enable precision treatments tailored to individual injury profiles. Emerging therapies, including neurostimulation and stem cell treatments, further expand possibilities for effective, patient-specific interventions in TBI management
- Personalized and targeted therapies present a transformative approach to managing Traumatic Brain Injury (TBI) by tailoring interventions to individual genetic and molecular profiles. These strategies focus on specific biomarkers and cellular processes to reduce secondary damage and improve recovery. By optimizing treatment, personalized therapies enhance outcomes and promote long-term functional recovery for TBI patients.
Restraint/Challenge
“Difficulties in Overcoming the Blood-Brain Barrier for TBI Treatment”
- A significant challenge in Traumatic Brain Injury (TBI) treatment is the disruption of the Blood-Brain Barrier (BBB). After a TBI, the Blood-Brain Barrier (BBB )often becomes compromised, allowing harmful substances to enter the brain, which can worsen injury and hinder recovery. This creates difficulty in delivering therapeutic agents effectively, limiting the success of many treatments designed to aid recovery and protect brain tissue.
- Furthermore, restoring the integrity of the Blood-Brain Barrier (BBB) without causing additional harm remains a major challenge. Developing targeted delivery systems that can bypass the damaged barrier without introducing further risks is crucial for improving TBI treatment outcomes.
For instance,
- In January 2022, Springer Nature Publishing Inc reported that Blood-Brain Barrier (BBB) it restricts the delivery of therapeutic agents to the brain. Even when the BBB is compromised after injury, many drugs, particularly large molecules, still struggle to penetrate it, limiting the effectiveness of treatments and complicating targeted therapies.
- In June 2024, nature reviews neurology reported that BBB dysfunction can persist from days to years after TBI, contributing to long-term neurological complications. This dysfunction is linked to oedema, neuroinflammation, and alterations in neuronal networks, complicating treatment strategies and leading to cognitive impairments, depression, and post-traumatic epilepsy, thus challenging effective recovery and therapeutic approaches
- La rupture de la barrière hémato-encéphalique (BHE) représente un défi majeur dans le traitement des traumatismes crâniens (TC), car elle limite l'efficacité des traitements et aggrave les lésions cérébrales. Un dysfonctionnement persistant de la BHE peut entraîner des complications à long terme, notamment une inflammation, un œdème cérébral et des troubles cognitifs. Si des approches comme la thérapie par piégeage des ROS sont prometteuses pour améliorer la fonction cérébrale, la nature fluctuante des lésions de la BHE complique les stratégies thérapeutiques. Pour améliorer les résultats des TCE, il est crucial de développer des systèmes d'administration de médicaments innovants et de meilleures méthodes de surveillance de l'intégrité de la BHE, permettant des traitements plus efficaces et réduisant les troubles neurologiques à long terme.
Portée du marché du traitement des lésions cérébrales traumatiques
Le marché est segmenté en fonction du traitement, de l’âge du patient, du sexe, de la cause de la blessure et de l’utilisateur final.
|
Segmentation |
Sous-segmentation |
|
Par traitement |
|
|
Par âge du patient |
|
|
Par sexe |
|
|
Par cause de blessure |
|
|
Par utilisateur final |
|
Analyse du marché du traitement des traumatismes crâniens par pays
« L'Afrique du Sud est le pays dominant sur le marché du traitement des traumatismes crâniens »
- L'Afrique du Sud devrait dominer le marché des traumatismes crâniens grâce à la hausse des accidents de la route et à l'amélioration des infrastructures de santé. Le renforcement des initiatives gouvernementales et des programmes de sensibilisation soutient la croissance du marché.
« L'Afrique du Sud devrait enregistrer le taux de croissance le plus élevé »
- Le marché sud-
Part de marché du traitement des lésions cérébrales traumatiques
Le paysage concurrentiel du marché fournit des détails par concurrent. Il comprend la présentation de l'entreprise, ses données financières, son chiffre d'affaires, son potentiel de marché, ses investissements en recherche et développement, ses nouvelles initiatives commerciales, sa présence au Moyen-Orient et en Afrique, ses sites et installations de production, ses capacités de production, ses forces et faiblesses, le lancement de nouveaux produits, leur ampleur et leur portée, ainsi que la domination de ses applications. Les données ci-dessus ne concernent que les activités des entreprises par rapport à leur marché.
Les principaux leaders du marché opérant sur le marché sont :
- Pfizer Inc. (États-Unis)
- Teva Pharmaceuticals US, Inc. (États-Unis)
- Fresenius SE & Co. KGaA (Fresenius Kabi AG) (Allemagne)
- Viatris Inc. (États-Unis)
- Amneal Pharmaceuticals LLC. (États-Unis)
- Dr. Reddy's Laboratories Ltd. (Inde)
- Sun Pharmaceutical Industries, Inc. (Inde)
- Lupin (Inde)
- Hikma (Jordanie)
- Aurobindo Pharma US (Inde)
- ICU Medical (États-Unis)
- B. Braun Medical Inc. (Allemagne)
- Alembic Pharmaceuticals Limited (Inde)
- Merz Therapeutics (Allemagne)
- Advacare (Afrique du Sud)
- Maxzimaa (Inde)
- Jedux Parenteral Private Limited (Inde)
- Sagent Pharmaceuticals, Inc. (États-Unis)
- Swiss Pharma Nigeria Limited (Nigéria)
Dernières évolutions du marché du traitement des traumatismes crâniens
- En février 2021, Fresenius Kabi a agrandi ses installations en Autriche, renforçant ainsi ses capacités de production et son innovation dans les domaines pharmaceutique et des technologies médicales. Cette expansion améliore l'efficacité de la production, assure un approvisionnement régulier en produits de soins intensifs et soutient les avancées de la recherche. En augmentant ses capacités et son excellence opérationnelle, l'entreprise renforce sa présence sur le marché et répond à la demande croissante de solutions de santé au Moyen-Orient et en Afrique.
- En février 2024, Viatris et Idorsia ont conclu un important partenariat de recherche et développement au Moyen-Orient et en Afrique afin de développer des thérapies innovantes dans de multiples domaines thérapeutiques. Ce partenariat s'appuie sur l'expertise d'Idorsia en matière de découverte de médicaments et sur la présence de Viatris au Moyen-Orient et en Afrique, accélérant le développement de traitements révolutionnaires et élargissant les portefeuilles de produits des deux entreprises, renforçant ainsi leur engagement à répondre aux besoins médicaux non satisfaits dans le monde entier.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END-USER COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 TECHNOLOGY ROADMAP
4.4 VALUE CHAIN ANALYSIS
4.5 OPPUTUNITY MAP ANALYSIS
4.6 REIMBURSEMENT FRAMEWORK
4.7 COST ANALYSIS BREAKDOWN
4.8 PENETRATION AND GROWTH PROSPECT MAPPING: MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET
4.9 KEY PRICING STRATEGIES: MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET
4.1 MICRO AND MACRO-ECONOMIC FACTORS: MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET
5 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING INCIDENCE OF TRAUMATIC BRAIN INJURY (TBI)
6.1.2 GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES IN TBI TREATMENT
6.1.3 TECHNOLOGICAL ADVANCEMENT FOR DIAGNOSIS OF TRAUMATIC BRAIN INJURIES (TBI)
6.1.4 ADVANCEMENTS IN NEUROPROTECTION AND PHARMACOTHERAPY FOR TBI TREATMENT
6.2 RESTRAINTS
6.2.1 SHORTAGE OF TRAINED NEUROLOGISTS AND NEUROSURGEONS
6.2.2 HIGH COST OF TRAUMATIC BRAIN INJURY (TBI) TREATMENT
6.3 OPPORTUNITIES
6.3.1 RISING PERSONALIZED & TARGETED THERAPIES IN TRAUMATIC BRAIN INJURY (TBI)
6.3.2 GROWING BRAIN STIMULATION TECHNIQUES IN TRAUMATIC BRAIN INJURY (TBI) TREATMENT
6.3.3 RISING ARTIFICIAL INTELLIGENCE (AI) APPLICATIONS IN DIAGNOSING TRAUMATIC BRAIN INJURY (TBI)
6.4 CHALLENGES
6.4.1 DIFFICULTIES IN OVERCOMING THE BLOOD-BRAIN BARRIER FOR TBI TREATMENT
6.4.2 ABSENCE OF STANDARDIZED TREATMENT PROTOCOLS IN TRAUMATIC BRAIN INJURY MANAGEMENT
7 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT
7.1 OVERVIEW
7.2 SURGERY
7.2.1 BRAIN BLEEDING TREATMENT
7.2.2 REHABILITATION
7.2.3 CLOTTED BLOOD REMOVAL
7.2.4 WINDOW OPENING IN SKULL
7.2.5 REPAIRING SKULL FRACTURES
7.3 IMMEDIATE EMERGENCY CARE
7.4 MEDICATIONS
7.4.1 DIURETICS
7.4.2 ANTI-SEIZURE DRUGS (ANTI-CONVULSANT)
7.4.3 ANALGESIC
7.4.4 COMA-INDUCING DRUGS
7.4.5 ANTI-DEPRESSANTS
7.4.6 ANTI-ANXIETY AGENT
7.4.7 ANTI-PSYCHOTICS
7.4.8 ANTI-COAGULANTS
7.4.9 OTHERS
7.4.9.1 Parenteral
7.4.9.2 Oral
7.4.9.3 Others
8 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE
8.1 OVERVIEW
8.2 CHILDREN
8.3 TEENAGER
8.4 ELDER
9 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER
9.1 OVERVIEW
9.2 MALE
9.3 FEMALE
10 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, CAUSE OF INJURY
10.1 OVERVIEW
10.2 FALLS
10.3 MOTOR VEHICLE TRAFFIC
10.4 SPORTS
10.5 OTHERS
11 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 NEUROLOGY CLINICS
11.4 INDEPENDENT PHARMACIES
11.5 OTHERS
12 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION
12.1 MIDDLE EAST AND AFRICA
12.1.1 SOUTH AFRICA
12.1.2 SAUDI ARABIA
12.1.3 U.A.E.
12.1.4 EGYPT
12.1.5 ISRAEL
12.1.6 REST OF MIDDLE EAST AND AFRICA
13 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 PFIZER INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 TEVA PHARMACEUTICALS USA, INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT/NEWS
15.3 FRESENIUS SE & CO. KGAA (FRESENIUS KABI AG)
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 VIATRIS INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 AMNEAL PHARMACEUTICALS LLC
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ADVACARE PHARMA
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 AUROBINDO PHARMA LIMITED
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 ALEMBIC PHARMACEUTICALS LIMITED
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 B. BRAUN SE
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT UPDATES
15.1 DR. REDDY’S LABORATORIES LTD.
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PIPELINE PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 ICU MEDICAL, INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT/NEWS
15.12 HIKMA PHARMACEUTICALS PLC
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PIPELINE PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 JEDUX PARENTERAL PRIVATE LIMITED
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 LUPIN
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENT
15.15 MERZ THERAPEUTICS
15.15.1 COMPANY SNAPSHOT
15.15.2 PIPELINE PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 MAXZIMAA
15.16.1 COMPANY SNAPSHOT
15.16.2 PIPELINE PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 SUN PHARMACEUTICAL INDUSTRIES LTD.
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENT
15.18 SWISS PHARMA NIGERIA LIMITED
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 SAGENT
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Liste des tableaux
TABLE 1 NON-INVASIVE THERAPEUTIC APPROACHES’ EFFICIENCY IN DIFFERENT PHASES OF TBI
TABLE 2 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 3 MIDDLE EAST AND AFRICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 4 MIDDLE EAST AND AFRICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 MIDDLE EAST AND AFRICA IMMEDIATE EMERGENCY CARE IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 6 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 7 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 9 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 10 MIDDLE EAST AND AFRICA CHILDREN IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 MIDDLE EAST AND AFRICA TEENAGER IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 12 MIDDLE EAST AND AFRICA ELDER IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 13 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 14 MIDDLE EAST AND AFRICA MALE IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 15 MIDDLE EAST AND AFRICA FEMALE IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 16 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 17 MIDDLE EAST AND AFRICA FALLS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 18 MIDDLE EAST AND AFRICA MOTOR VEHICLE TRAFFIC IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA SPORTS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 20 MIDDLE EAST AND AFRICA OTHERS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 21 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 22 MIDDLE EAST AND AFRICA HOSPITALS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 23 MIDDLE EAST AND AFRICA NEUROLOGY CLINICS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 24 MIDDLE EAST AND AFRICA INDEPENDENT PHARMACIES IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 25 MIDDLE EAST AND AFRICA OTHERS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 26 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 27 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 28 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 29 NORTH AMERICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 NORTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 31 NORTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 32 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 33 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 34 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 35 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 36 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 37 U.S. SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 38 U.S. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 U.S. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 40 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 41 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 42 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 43 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 44 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 45 CANADA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 46 CANADA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 CANADA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 48 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 49 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 50 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 51 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 52 MEXICO TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 53 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 54 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 55 EUROPE SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 56 EUROPE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 EUROPE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 58 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 59 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 60 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 61 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 62 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 63 GERMANY SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 GERMANY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 GERMANY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 66 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 67 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 68 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 69 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 70 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 71 U.K. SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 U.K. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 U.K. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 74 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 75 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 76 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 77 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 78 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 79 FRANCE SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 FRANCE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 FRANCE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 82 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 83 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 84 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 85 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 86 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 87 ITALY SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 ITALY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 ITALY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 90 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 91 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 92 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 93 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 94 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 95 SPAIN SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 SPAIN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 SPAIN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 98 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 99 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 100 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 101 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 102 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 103 RUSSIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 104 RUSSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 RUSSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 106 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 107 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 108 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 109 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 110 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 111 NETHERLANDS SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 112 NETHERLANDS MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 113 NETHERLANDS MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 114 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 115 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 116 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 117 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 118 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 119 SWITZERLAND SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 120 SWITZERLAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 SWITZERLAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 122 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 123 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 124 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 125 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 126 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 127 TURKEY SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 TURKEY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 TURKEY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 130 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 131 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 132 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 133 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 134 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 135 BELGIUM SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 136 BELGIUM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 137 BELGIUM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 138 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 139 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 140 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 141 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 142 REST OF EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 143 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 144 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 145 ASIA-PACIFIC SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 146 ASIA-PACIFIC MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 147 ASIA-PACIFIC MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 148 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 149 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 150 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 151 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 152 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 153 CHINA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 CHINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 CHINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 156 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 157 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 158 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 159 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 160 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 161 JAPAN SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 162 JAPAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 JAPAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 164 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 165 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 166 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 167 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 168 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 169 INDIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 INDIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 171 INDIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 172 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 173 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 174 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 175 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 176 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 177 SOUTH KOREA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 SOUTH KOREA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 SOUTH KOREA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 180 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 181 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 182 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 183 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 184 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 185 AUSTRALIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 186 AUSTRALIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 187 AUSTRALIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 188 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 189 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 190 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 191 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 192 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 193 SINGAPORE SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 194 SINGAPORE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 195 SINGAPORE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 196 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 197 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 198 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 199 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 200 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 201 THAILAND SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 THAILAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 203 THAILAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 204 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 205 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 206 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 207 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 208 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 209 MALAYSIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 210 MALAYSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 211 MALAYSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 212 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 213 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 214 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 215 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 216 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 217 INDONESIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 218 INDONESIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 INDONESIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 220 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 221 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 222 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 223 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 224 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 225 TAIWAN SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 TAIWAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 TAIWAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 228 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 229 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 230 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 231 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 232 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 233 NEW ZEALAND SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 234 NEW ZEALAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 235 NEW ZEALAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 236 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 237 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 238 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 239 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 240 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 241 PHILIPPINES SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 PHILIPPINES MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 243 PHILIPPINES MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 244 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 245 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 246 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 247 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 248 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 249 VIETNAM SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 VIETNAM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 251 VIETNAM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 252 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 253 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 254 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 255 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 256 REST OF ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 257 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 258 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 259 MIDDLE EAST AND AFRICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 260 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 261 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 262 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 263 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 264 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 265 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 266 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 267 SOUTH AFRICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 268 SOUTH AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 SOUTH AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 270 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 271 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 272 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 273 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 274 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 275 SAUDI ARABIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 276 SAUDI ARABIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 277 SAUDI ARABIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 278 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 279 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 280 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 281 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 282 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 283 U.A.E SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 284 U.A.E MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 U.A.E MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 286 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 287 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 288 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 289 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 290 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 291 EGYPT SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 292 EGYPT MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 293 EGYPT MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 294 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 295 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 296 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 297 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 298 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 299 ISRAEL SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 ISRAEL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 301 ISRAEL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 302 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 303 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 304 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 305 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 306 REST OF MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 307 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 308 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 309 SOUTH AMERICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 SOUTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 SOUTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 312 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 313 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 314 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 315 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 316 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 317 BRAZIL SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 BRAZIL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 319 BRAZIL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 320 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 321 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 322 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 323 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 324 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 325 ARGENTINA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 326 ARGENTINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 ARGENTINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 328 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)
TABLE 329 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 330 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 331 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 332 REST OF SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
Liste des figures
FIGURE 1 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: MARKET END-USER COVERAGE GRID
FIGURE 9 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: SEGMENTATION
FIGURE 11 INCREASING INCIDENCE OF TRAUMATIC BRAIN INJURY (TBI) IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 12 SURGERY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 15 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: EXECUTIVE SUMMARY
FIGURE 16 STRATEGIC DECISIONS
FIGURE 17 DROC ANALYSIS
FIGURE 18 TBI-RELATED DEATHS FROM 2018 TO 2024
FIGURE 19 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, 2024
FIGURE 20 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, 2025 TO 2032 (USD THOUSAND)
FIGURE 21 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, CAGR (2025- 2032)
FIGURE 22 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 23 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, 2024
FIGURE 24 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, 2025 TO 2032 (USD THOUSAND)
FIGURE 25 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, CAGR (2025- 2032)
FIGURE 26 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, LIFELINE CURVE
FIGURE 27 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER, 2024
FIGURE 28 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER, 2025-2032 (USD THOUSAND)
FIGURE 29 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER CAGR (2025-2032)
FIGURE 30 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER, LIFELINE CURVE
FIGURE 31 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, 2024
FIGURE 32 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, 2025-2032 (USD THOUSAND)
FIGURE 33 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, CAGR (2025-2032)
FIGURE 34 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, LIFELINE CURVE
FIGURE 35 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, 2024
FIGURE 36 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, 2025-2032 (USD THOUSAND)
FIGURE 37 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, CAGR (2025-2032)
FIGURE 38 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 39 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: SNAPSHOT (2024)
FIGURE 40 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
FIGURE 41 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
FIGURE 42 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
FIGURE 43 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
